Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1994-4-5
|
pubmed:abstractText |
Effects of repeated administration of KW-3902, a novel adenosine A1-receptor antagonist, on its pharmacological actions were studied with regards to: 1) in vivo adenosine A1-antagonism, 2) diuretic effects and 3) renal protective effects against glycerol-induced acute renal failure (ARF). After repeated oral administration of KW-3902 (0.1 mg/kg/day) for 24 days, neither enhancement of the sensitivity to 5'-N-ethylcarboxamidoadenosine (NECA) nor reduction of the inhibitory effect of KW-3902 on the NECA-induced bradycardic response were observed. After repeated oral administration of KW-3902 (0.01 and 0.1 mg/kg/day) for 20 days, the diuretic effects of KW-3902 did not change. Renal protective effects against glycerol-induced ARF were not reduced by repeated oral administration of KW-3902 (0.01 and 0.1 mg/kg/day) for 23 days. These results suggest that repeated oral administration of KW-3902 has no effect on its pharmacological actions. Additionally, changes in serum parameters, which occurred after repeated administration of furosemide or trichlormethiazide, were minimal after repeated oral administration of KW-3902 (0.001-1 mg/kg/day) for 27 days. From these results, KW-3902 proved to be a diuretic which has renal protective effects with less side effects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1,3-dipropyl-8-(3-noradamantyl)xanth...,
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine,
http://linkedlifedata.com/resource/pubmed/chemical/Adenosine-5'-(N-ethylcarboxamide),
http://linkedlifedata.com/resource/pubmed/chemical/Diuretics,
http://linkedlifedata.com/resource/pubmed/chemical/Furosemide,
http://linkedlifedata.com/resource/pubmed/chemical/Glycerol,
http://linkedlifedata.com/resource/pubmed/chemical/Purinergic P1 Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Trichlormethiazide,
http://linkedlifedata.com/resource/pubmed/chemical/Xanthines
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0021-5198
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
513-9
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8121084-Acute Kidney Injury,
pubmed-meshheading:8121084-Adenosine,
pubmed-meshheading:8121084-Adenosine-5'-(N-ethylcarboxamide),
pubmed-meshheading:8121084-Administration, Oral,
pubmed-meshheading:8121084-Animals,
pubmed-meshheading:8121084-Diuretics,
pubmed-meshheading:8121084-Furosemide,
pubmed-meshheading:8121084-Glycerol,
pubmed-meshheading:8121084-Heart Rate,
pubmed-meshheading:8121084-Male,
pubmed-meshheading:8121084-Purinergic P1 Receptor Antagonists,
pubmed-meshheading:8121084-Rats,
pubmed-meshheading:8121084-Rats, Wistar,
pubmed-meshheading:8121084-Trichlormethiazide,
pubmed-meshheading:8121084-Urination,
pubmed-meshheading:8121084-Xanthines
|
pubmed:year |
1993
|
pubmed:articleTitle |
Effects of repeated administration of KW-3902, a novel adenosine A1-receptor antagonist, on its pharmacological actions.
|
pubmed:affiliation |
Department of Pharmacology, Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|